Literature DB >> 16827693

The hairless guinea-pig as a model for treatment of acute irritation in humans.

F Andersen1, K Hedegaard, A Fullerton, T K Petersen, C Bindslev-Jensen, K E Andersen.   

Abstract

BACKGROUND: The effect of six skin care formulations on experimentally induced acute irritation was studied in hairless guinea-pigs (HLGP) and in human volunteers (HV). The formulations were a basic cream, a carbomer cream and four modifications of the carbomer cream, containing either 10% isopropyl palmitate (IPP cream), 10% glycerol (glycerol cream), 19.5% canola oil (canola oil cream) or 0.5% (-)-alpha-bisabolol (bisabolol cream).
METHODS: Acute irritation was induced by occlusive tests with 1% sodium lauryl sulfate aq. in both HLGP and HV, and in HV also by using nonanoic acid in n-propanol (NON) 20%. The irritant reactions were treated twice daily with the formulations from the time of removal of the patches. Evaluation of skin irritation and efficacy of treatments was performed daily for 4 days using clinical scoring, evaporimetry (transepidermal water loss), hydration measurement and colorimetry.
RESULTS: The glycerol cream was the only product showing effects potentially better than no treatment in HV.
CONCLUSION: The HLGP was too sensitive an animal model as a predictor for effect in humans. There was no difference in efficacy of the formulations against the two different irritants in HV.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16827693     DOI: 10.1111/j.0909-752X.2006.00148.x

Source DB:  PubMed          Journal:  Skin Res Technol        ISSN: 0909-752X            Impact factor:   2.365


  1 in total

1.  Insecticidal activity of Vanillosmopsis arborea essential oil and of its major constituent α-bisabolol against Callosobruchus maculatus (Coleoptera: Chrysomelidae).

Authors:  Eridiane da Silva Moura; Lêda Rita D' Antonino Faroni; José Cola Zanuncio; Fernanda Fernandes Heleno; Lucas Henrique Figueiredo Prates
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.